Hangzhou Fuluo Biological Technology Co.,Ltd.
High quality, competitive price, fast delivery
Payment & Shipping Terms:
|Product Name::||Mibolerone||CAS No:||3704-09-4|
|Grade:||Pharmaceutical Grade||Appearance:||White Crystalline Powder|
Bodybuilding Supplement Androgenic Prohormone Mibolerone Powder
If you are interested in my products,please contact:
CAS 3704-09-4 Mibolerone
|Appearance:||white crystalline powder|
Mibolerone is an oral anabolic androgenic steroid derived from the anabolic steroid Nandrolone. Specifically, this is a structurally altered form of Nandrolone. Mibolerone exist by adding a methyl group to the 7th and 17th position of the Nandrolone hormone. The added methyl group at the 7th position increases the hormone’s androgenicity and prevents the action of the 5-alpha reductase enzyme. The added methyl group at the 17th position protects the hormone’s oral ingestion. This classifies Mibolerone as a C17-alpha alkylated (C17-aa) anabolic steroid.
Most people use it for the strength gains it imparts or for a burst of aggressive energy in strength sports; however, used at a low dose, due to its high AR and PR affinities, this drug can result in pretty substantial mass gains over time.
Mibolerone Dosages and Uses:
Most athletes use about 5mgs about 30min prior to training or competition. It is not really “stacked” with anything except cardarine. It is usually used just prior to important training sessions or competitions. Many athletes already using heavy doses of steroids add in Mibolerone as a pre-event enhancer.
The half-life of mibolerone is rather short at around 4hrs, so athletes who want to harness the full power of this product use it about 20 to 30 minutes before they will need the boost. Some competitors may dose the product a second time in the same day when doing long events, usually allowing for a full 5hr time span in between 5mg servings
|Trenbolone Series||CAS No.|
|Trenbolone Hexahydrobenzyl Carbonate||23454-33-3|
|Testerone series||CAS NO.|
|1-testosterone cypionate , Dihydroboldenone||65-06-5|